Alacrita

Alacrita operates as a specialized consulting firm, offering integrated drug development and business strategy services to the life sciences sector. Its core differentiator is a flexible, on-demand network of 350+ senior consultants with an average of 20+ years of industry experience, enabling the assembly of bespoke teams for client projects. The company supports clients across three core service pillars: Product Development (from opportunity mapping to CMC), Enterprise Development (business planning, fundraising, virtual biotech support), and Business Development (due diligence, licensing, partnering). This model positions Alacrita as a strategic partner for biotechs, pharma companies, and investors navigating complex R&D and commercial challenges.

Proprietary network and operational model comprising a core team and a curated global network of over 350 independent life science consultants with deep, hands-on industry experience across 29 functional disciplines, 22 disease areas, and 18 product modalities.

Alacrita competes in a crowded life sciences consulting market against large global CROs (e.g., IQVIA, Parexel), broad management consultancies (e.g., BCG, Bain), and numerous boutique specialist firms. Its differentiation lies in its hybrid model of strategic oversight combined with a deep, flexible network of hands-on industry veterans.